CHA submitted a response to the request for information (RFI) on the 340B program. Our response calls on Congress to strengthen the program to ensure that children have access to needed medications.
CHA Responds to Senate 340B Request for Information
Our response calls on Congress to strengthen the program to ensure that children have access to needed medications.
Related Content
CHA Submits Comments for 2025 OPPS and PFS Proposed Rules
High-Cost Therapies for Pediatrics
CHA Submits Energy and Commerce Committee Statement on Oversight of the 340B Drug Pricing Program
CHA Submits Comments for 2025 OPPS and PFS Proposed Rules
CHA highlighted pediatric considerations in response to certain provisions within the proposed rules, which could have a downstream impact on Medicaid.
Sep. 19, 2024
High-Cost Therapies for Pediatrics
Pediatric HCTs are innovative and lifesaving or life-altering treatments for children with chronic, rare, and complex conditions.
Sep. 06, 2024
CHA Submits Energy and Commerce Committee Statement on Oversight of the 340B Drug Pricing Program
Children's Hospital Association urges the committee to work with provider stakeholders to enhance the effectiveness and integrity of the program for children's health.
July 09, 2024
